Difficulty: Medium
Average Score: 68%
Practice
The reason for preferring ethosuximide to valproate for uncomplicated absence seizures is:
Correct answer
B
Rationale
In the context of treating uncomplicated absence seizures, the preference for ethosuximide over valproate is primarily due to valproate's idiosyncratic hepatotoxicity. Ethosuximide is considered safer and better tolerated in this specific type of seizure disorder.
Valproate, while effective in treating various seizure types, carries a risk of hepatotoxicity that is particularly concerning in patients with absence seizures. This idiosyncratic reaction can lead to severe liver damage and even failure, making it a less favorable option when compared to ethosuximide for this specific population.
The other options provided in the question are incorrect. Option A, stating that ethosuximide is more effective, is not the primary reason for choosing it over valproate in uncomplicated absence seizures. While both medications can be effective, the safety profile of ethosuximide in this context makes it the preferred choice. Option C, citing greater CNS depressant activity, is also not a deciding factor in this specific medication selection.
In an educational context, understanding the rationale behind medication choices for specific seizure types is crucial for nursing pharmacology practice. By grasping the nuances of each medication's efficacy and safety profile, nurses can optimize patient care and minimize potential risks associated with treatment. This knowledge empowers nurses to make informed decisions that prioritize patient safety and well-being.
Valproate, while effective in treating various seizure types, carries a risk of hepatotoxicity that is particularly concerning in patients with absence seizures. This idiosyncratic reaction can lead to severe liver damage and even failure, making it a less favorable option when compared to ethosuximide for this specific population.
The other options provided in the question are incorrect. Option A, stating that ethosuximide is more effective, is not the primary reason for choosing it over valproate in uncomplicated absence seizures. While both medications can be effective, the safety profile of ethosuximide in this context makes it the preferred choice. Option C, citing greater CNS depressant activity, is also not a deciding factor in this specific medication selection.
In an educational context, understanding the rationale behind medication choices for specific seizure types is crucial for nursing pharmacology practice. By grasping the nuances of each medication's efficacy and safety profile, nurses can optimize patient care and minimize potential risks associated with treatment. This knowledge empowers nurses to make informed decisions that prioritize patient safety and well-being.